St Andrew's Ipswich Private Hospital
Dr Ross Tomlinson is a clinical haematologist at Icon Cancer Centre . Dr Tomlinson is a strong advocate for clinical trials and local research, ensuring patients have access to the latest treatment options close to home. He is committed to providing individualised, patient-centred care, and works collaboratively with his patients, their loved ones and general practitioners to achieve the best possible outcome.
Level, Consulting Suites
St Andrew's Ipswich Private Hospital, Cnr Roderick and Pring Street
Ipswich, QLD, 4305
07 3737 4643
07 37374601
Claim your profile
Dr Ross Tomlinson is a strong advocate for clinical trials and local research, ensuring patients have access to the latest treatment options close to home. He is committed to providing individualised, patient-centred care, and works collaboratively with his patients, their loved ones and general practitioners to achieve the best possible outcome.
Dr Ross Tomlinson is a clinical haematologist at Icon Cancer Centre . In 2012 he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Bond University. He is experienced in caring for a wide range of malignant and non-malignant blood disorders including lymphoma, leukaemia, multiple myeloma, myelodysplastic syndromes, thrombosis and haemostasis.Dr Tomlinson subsequently commenced clinical and laboratory haematology specialist training at the Royal Brisbane and Women’s Hospital and Toowoomba Base Hospital.
Dr Tomlinson maintains a strong interest in clinical trials, clinical research and medical education in both his private practice and roles at Princess Alexandra Hospital. He has published several clinical research articles in leading peer-reviewed journals and is a regular presenter at national and international haematology conferences. Dr Tomlinson is also an associate lecturer at the University of Queensland.
Dr Tomlinson is a fellow of the Royal Australasian College of Physicians (FRACP) and Royal College of Pathologists of Australasia (FRCPA). He is also a member of several leading cancer trial and research groups including the Australasian Leukaemia & Lymphoma Group (ALLG), American Society of Haematology (ASH) and Haematology Society of Australia and New Zealand (HSANZ).